Teva Pharmaceuticals USA Inc recalls Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by:
Teva Pharmaceuticals recalls Matzim LA 240mg extended-release tablets due to failed dissolution specifications. This may affect medication effectiveness. Check your product details to see if you need to take action.
Lower-risk recall
Failed Dissolution Specifications: below specification limits for dissolution.
Contact the company & request your remedy
What happened, in plain English
Teva Pharmaceuticals is recalling Matzim LA (Diltiazem Hydrochloride) 240mg extended-release tablets because they may not dissolve properly as intended. This could lead to inconsistent medication levels in the body, potentially affecting treatment effectiveness. Read more at govinfonow.com/recall/34396-teva-matzim-la-240mg-tablets-recall-failed-dissolution-specifications.
Source Summary by GovInfoNow · govinfonow.com/recall/34396-teva-matzim-la-240mg-tablets-recall-failed-dissolution-specifications · Updated August 18, 2026 · FDA enforcement record: FDA #D-1303-2022
Cite this page
“Teva Matzim LA 240mg Tablets Recall: Failed Dissolution Specifications.” GovInfoNow, updated August 18, 2026. https://govinfonow.com/recall/34396-teva-matzim-la-240mg-tablets-recall-failed-dissolution-specifications. Based on FDA recall #D-1303-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1303-2022%22&limit=1).
Why it’s dangerous
The tablets may not dissolve properly in the stomach, which could lead to inconsistent medication levels. This might cause the medication to not work as intended, potentially affecting heart condition treatment.
Who’s affected
People with prescriptions for Matzim LA 240mg tablets who received this specific product from the manufacturer. Those with heart conditions requiring this medication are most at risk.
How to tell if you have this one
Check for the product name Matzim LA, 240mg, 30-count bottles, Rx Only. The lot number 1411596A and expiration date 09/22 are specific identifiers for this recall.
- Brand
Teva Pharmaceuticals- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide in the USA and Puerto Rico
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-1302-2022 | Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 180 mg, 30-count bottle, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314, USA; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA; NDC 52544-691-30.; Lot 1411593A, Exp 09/22 | 8022 bottles | 52544-691-30, 52544-691-19, 52544-691-10, 52544-692-30, 52544-692-19, 52544-692-10, 52544-693-30, 52544-693-19, 52544-693-10, 52544-694-30, 52544-694-19, 52544-694-10, 52544-695-30, 52544-695-19, 52544-695-10 |
| D-1303-2022 | Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30-count bottles, Rx Only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL USA 33314, USA, Distributed by: Actavis Pharma Inc., Parsippany, NJ 07054 USA; NDC 58544-692-30.; Lot 1411596A, Exp 09/22 | 5677 bottles | — |
What to do — step by step
Check Product Details
Look for the product name Matzim LA, 240mg, 30-count bottles, Rx Only with lot number 1411596A and expiration date 09/22.
Questions people ask
Is this recall dangerous?
The recall is for medication that may not dissolve properly, which could affect treatment effectiveness. However, it does not pose an immediate risk of serious injury.
How do I know if I have the recalled product?
Check for Matzim LA 240mg tablets with lot number 1411596A and expiration date 09/22.
What should I do if I have the recalled product?
The recall does not specify a remedy, so contact your healthcare provider for advice on whether to continue using the medication.
Contact Teva Pharmaceuticals
We’ve drafted a message you can send Teva Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1303-2022 — Teva Pharmaceuticals Teva Pharmaceuticals Hello, I own a Teva Pharmaceuticals that is covered by recall D-1303-2022 from Teva Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1303-2022 (July 21, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1303-2022 to see it in context.
- Plain-language summary written by qwen3:4b on August 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.